| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 28-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 18 new Laggards. | 58 |
$20 |
| 28-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: CEL-SCI CORP | 5 |
$25 |
| 28-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Cel-Sci Corp | 5 |
$25 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | CEL SCI CP (CVM=US) 12-months forecast | 1 |
$15 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | CEL SCI CP (CVM=US) 2-weeks forecast | 1 |
$10 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ALSE , CVM , CHTP , CYCC , CUR -- DRUGS | 3 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CEL-SCI -- CVM | 1 |
$4 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| CEL-SCI Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Argus Research Corporation | David Coleman | Vickers Weekly Insider, 11/23/09 | 52 |
$50 |
0.22% Nasdaq 
0.11%
Research Reports
